Health
BioNTech Founders to Leave and Launch New mRNA Company
Ugur Sahin and Ozlem Tureci will exit BioNTech by year-end to start a company focused on next-generation mRNA innovations.
Key Takeaways
- COVID vaccine architects Sahin and Tureci leaving BioNTech by end of 2026
- New company will pursue frontier mRNA applications in cancer and rare diseases
- BioNTech to narrow focus to its existing late-stage clinical pipeline
DE
DT Editorial AI··via endpoints.news